-
1
Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
2
Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
3
Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
4
Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
5
Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
6
Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
7
Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
8
Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
9
Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
10
Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Baskı/Yayın Bilgisi 2025Konular: -
11
-
12
-
13
-
14
Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: -
15
Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: -
16
Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: -
17
Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: -
18
Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: -
19
Asymmetric Total Synthesis and Anti-Inflammatory Activity of Berbamine, Oxyacanthine, and Related Intermediates
Baskı/Yayın Bilgisi 2025Konular: